Jason McCarthy
Stock Analyst at Maxim Group
(1.18)
# 3,700
Out of 4,981 analysts
169
Total ratings
29.08%
Success rate
-11.21%
Average return
Main Sectors:
Stocks Rated by Jason McCarthy
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CNSP CNS Pharmaceuticals | Upgrades: Buy | $20 | $7.39 | +170.64% | 3 | Sep 12, 2025 | |
NEUP Neuphoria Therapeutics | Maintains: Buy | $18 → $35 | $13.01 | +169.02% | 1 | Sep 11, 2025 | |
CHRS Coherus Oncology | Upgrades: Buy | $4 | $1.29 | +210.08% | 2 | Sep 4, 2025 | |
PSTV Plus Therapeutics | Maintains: Buy | $4 → $3 | $0.45 | +570.69% | 3 | Aug 18, 2025 | |
RVPH Reviva Pharmaceuticals Holdings | Maintains: Buy | $5 → $2 | $0.44 | +352.18% | 6 | Aug 15, 2025 | |
AKTX Akari Therapeutics, | Initiates: Buy | $5 | $0.79 | +533.71% | 1 | Jul 18, 2025 | |
SLS SELLAS Life Sciences Group | Maintains: Buy | $4 → $7 | $1.85 | +278.38% | 4 | Jul 16, 2025 | |
INMB INmune Bio | Maintains: Buy | $30 → $8 | $2.01 | +298.01% | 2 | Jul 2, 2025 | |
KZIA Kazia Therapeutics | Maintains: Buy | $15 | $8.00 | +87.50% | 3 | Jun 11, 2025 | |
CTXR Citius Pharmaceuticals | Downgrades: Hold | n/a | $1.21 | - | 1 | May 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $3.88 | +106.19% | 2 | May 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $3 | $0.70 | +331.10% | 1 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $5.40 | +1,011.11% | 1 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.08 | - | 2 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.44 | +581.97% | 1 | May 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $20 | $2.41 | +729.88% | 2 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.42 | - | 2 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.76 | +127.27% | 1 | Mar 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 | $0.36 | +999.51% | 3 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.94 | +240.72% | 1 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $1.28 | +134.38% | 2 | Mar 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.18 | +2,145.93% | 1 | Feb 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $4.88 | +145.90% | 2 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $2.25 | +566.67% | 2 | Jan 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $110 | $69.00 | +59.42% | 2 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $224 → $140 | $2.58 | +5,326.36% | 2 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $114.55 | - | 7 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.60 | +275.00% | 1 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $12 | $5.20 | +130.77% | 2 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.83 | - | 4 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $25 | $2.48 | +908.06% | 1 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $25 | $6.36 | +293.08% | 2 | Sep 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $25 | $7.75 | +222.58% | 2 | Sep 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $14.82 | -19.03% | 5 | Sep 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $10 | $7.69 | +30.04% | 2 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $5 | $1.63 | +206.75% | 2 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $10 | $0.84 | +1,097.60% | 2 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.94 | +219.15% | 1 | May 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $6 | $4.63 | +29.59% | 1 | Apr 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.28 | - | 2 | Nov 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.15 | - | 4 | Sep 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.66 | +502.41% | 1 | Sep 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $3.95 | +912.66% | 1 | Sep 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 | $3.39 | +784.96% | 4 | Sep 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 | $1.51 | +3,078.81% | 5 | Jul 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $10 | $1.64 | +509.76% | 2 | May 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $400 | $394.53 | +1.39% | 4 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $49.48 | - | 2 | Mar 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.54 | +936.27% | 1 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $60 | $3.87 | +1,450.39% | 2 | Mar 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $8 | $3.08 | +159.74% | 1 | Nov 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.85 | - | 1 | Nov 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.38 | - | 5 | Nov 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.93 | - | 3 | Oct 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $5 | $0.66 | +662.08% | 1 | Aug 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.35 | - | 1 | Aug 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $0.39 | +1,175.18% | 1 | Jun 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.29 | - | 4 | May 26, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $0.70 | +12,722.34% | 2 | May 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $900 | $2.65 | +33,862.26% | 1 | Jan 19, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $4.31 | +5,468.45% | 1 | Nov 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.09 | - | 1 | Nov 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $224 | $3.22 | +6,856.52% | 1 | Oct 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.16 | - | 4 | Oct 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4,500 | $0.97 | +463,865.36% | 1 | Jun 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $9.44 | +853.39% | 1 | Jun 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $360 | $5.80 | +6,106.90% | 1 | May 20, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $8.88 | +35.14% | 1 | Apr 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.34 | - | 4 | Mar 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.23 | +1,119.51% | 1 | Mar 10, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $80 | $2.11 | +3,691.47% | 3 | Feb 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.31 | - | 3 | Jan 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $170 | $32.05 | +430.42% | 1 | Nov 19, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $7.09 | +97.46% | 1 | Jul 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.84 | - | 2 | Dec 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $1.12 | +3,471.43% | 2 | Oct 16, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $16.11 | -25.51% | 3 | Jul 27, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $48 | $1.83 | +2,522.95% | 1 | Jun 22, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $14 | $24.81 | -43.57% | 2 | Jun 1, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $12 | $25.51 | -52.96% | 2 | May 11, 2018 |
CNS Pharmaceuticals
Sep 12, 2025
Upgrades: Buy
Price Target: $20
Current: $7.39
Upside: +170.64%
Neuphoria Therapeutics
Sep 11, 2025
Maintains: Buy
Price Target: $18 → $35
Current: $13.01
Upside: +169.02%
Coherus Oncology
Sep 4, 2025
Upgrades: Buy
Price Target: $4
Current: $1.29
Upside: +210.08%
Plus Therapeutics
Aug 18, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.45
Upside: +570.69%
Reviva Pharmaceuticals Holdings
Aug 15, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.44
Upside: +352.18%
Akari Therapeutics,
Jul 18, 2025
Initiates: Buy
Price Target: $5
Current: $0.79
Upside: +533.71%
SELLAS Life Sciences Group
Jul 16, 2025
Maintains: Buy
Price Target: $4 → $7
Current: $1.85
Upside: +278.38%
INmune Bio
Jul 2, 2025
Maintains: Buy
Price Target: $30 → $8
Current: $2.01
Upside: +298.01%
Kazia Therapeutics
Jun 11, 2025
Maintains: Buy
Price Target: $15
Current: $8.00
Upside: +87.50%
Citius Pharmaceuticals
May 23, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.21
Upside: -
May 20, 2025
Upgrades: Buy
Price Target: $8
Current: $3.88
Upside: +106.19%
May 19, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.70
Upside: +331.10%
May 19, 2025
Initiates: Buy
Price Target: $60
Current: $5.40
Upside: +1,011.11%
May 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $5.08
Upside: -
May 12, 2025
Initiates: Buy
Price Target: $3
Current: $0.44
Upside: +581.97%
May 8, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $2.41
Upside: +729.88%
May 8, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.42
Upside: -
Mar 27, 2025
Initiates: Buy
Price Target: $4
Current: $1.76
Upside: +127.27%
Mar 25, 2025
Upgrades: Buy
Price Target: $4
Current: $0.36
Upside: +999.51%
Mar 21, 2025
Initiates: Buy
Price Target: $10
Current: $2.94
Upside: +240.72%
Mar 10, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $1.28
Upside: +134.38%
Feb 24, 2025
Initiates: Buy
Price Target: $4
Current: $0.18
Upside: +2,145.93%
Jan 30, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $4.88
Upside: +145.90%
Jan 16, 2025
Maintains: Buy
Price Target: $8 → $15
Current: $2.25
Upside: +566.67%
Nov 15, 2024
Maintains: Buy
Price Target: $60 → $110
Current: $69.00
Upside: +59.42%
Nov 13, 2024
Maintains: Buy
Price Target: $224 → $140
Current: $2.58
Upside: +5,326.36%
Nov 8, 2024
Downgrades: Hold
Price Target: n/a
Current: $114.55
Upside: -
Nov 7, 2024
Initiates: Buy
Price Target: $6
Current: $1.60
Upside: +275.00%
Nov 1, 2024
Maintains: Buy
Price Target: $22 → $12
Current: $5.20
Upside: +130.77%
Oct 31, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.83
Upside: -
Oct 25, 2024
Upgrades: Buy
Price Target: $25
Current: $2.48
Upside: +908.06%
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $25
Current: $6.36
Upside: +293.08%
Sep 24, 2024
Maintains: Buy
Price Target: $18 → $25
Current: $7.75
Upside: +222.58%
Sep 24, 2024
Upgrades: Buy
Price Target: $12
Current: $14.82
Upside: -19.03%
Aug 6, 2024
Maintains: Buy
Price Target: $8 → $10
Current: $7.69
Upside: +30.04%
Aug 6, 2024
Maintains: Buy
Price Target: $30 → $5
Current: $1.63
Upside: +206.75%
May 9, 2024
Maintains: Buy
Price Target: $4 → $10
Current: $0.84
Upside: +1,097.60%
May 6, 2024
Initiates: Buy
Price Target: $3
Current: $0.94
Upside: +219.15%
Apr 3, 2024
Upgrades: Buy
Price Target: $6
Current: $4.63
Upside: +29.59%
Nov 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.28
Upside: -
Sep 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.15
Upside: -
Sep 12, 2023
Initiates: Buy
Price Target: $10
Current: $1.66
Upside: +502.41%
Sep 12, 2023
Initiates: Buy
Price Target: $40
Current: $3.95
Upside: +912.66%
Sep 5, 2023
Maintains: Buy
Price Target: $30
Current: $3.39
Upside: +784.96%
Jul 24, 2023
Upgrades: Buy
Price Target: $48
Current: $1.51
Upside: +3,078.81%
May 18, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $1.64
Upside: +509.76%
May 3, 2023
Maintains: Buy
Price Target: $325 → $400
Current: $394.53
Upside: +1.39%
Mar 29, 2023
Downgrades: Hold
Price Target: n/a
Current: $49.48
Upside: -
Mar 10, 2023
Initiates: Buy
Price Target: $16
Current: $1.54
Upside: +936.27%
Mar 9, 2023
Maintains: Buy
Price Target: $30 → $60
Current: $3.87
Upside: +1,450.39%
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $8
Current: $3.08
Upside: +159.74%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.85
Upside: -
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.38
Upside: -
Oct 12, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.93
Upside: -
Aug 23, 2022
Maintains: Buy
Price Target: $8 → $5
Current: $0.66
Upside: +662.08%
Aug 17, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.35
Upside: -
Jun 17, 2022
Initiates: Buy
Price Target: $5
Current: $0.39
Upside: +1,175.18%
May 26, 2022
Downgrades: Hold
Price Target: n/a
Current: $4.29
Upside: -
May 23, 2022
Reiterates: Buy
Price Target: $90
Current: $0.70
Upside: +12,722.34%
Jan 19, 2022
Initiates: Buy
Price Target: $900
Current: $2.65
Upside: +33,862.26%
Nov 29, 2021
Initiates: Buy
Price Target: $240
Current: $4.31
Upside: +5,468.45%
Nov 19, 2021
Downgrades: Hold
Price Target: n/a
Current: $6.09
Upside: -
Oct 29, 2021
Initiates: Buy
Price Target: $224
Current: $3.22
Upside: +6,856.52%
Oct 4, 2021
Downgrades: Hold
Price Target: n/a
Current: $4.16
Upside: -
Jun 28, 2021
Initiates: Buy
Price Target: $4,500
Current: $0.97
Upside: +463,865.36%
Jun 28, 2021
Initiates: Buy
Price Target: $90
Current: $9.44
Upside: +853.39%
May 20, 2021
Initiates: Buy
Price Target: $360
Current: $5.80
Upside: +6,106.90%
Apr 19, 2021
Initiates: Buy
Price Target: $12
Current: $8.88
Upside: +35.14%
Mar 29, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.34
Upside: -
Mar 10, 2021
Initiates: Buy
Price Target: $15
Current: $1.23
Upside: +1,119.51%
Feb 16, 2021
Maintains: Buy
Price Target: $14 → $80
Current: $2.11
Upside: +3,691.47%
Jan 7, 2021
Upgrades: Buy
Price Target: n/a
Current: $5.31
Upside: -
Nov 19, 2020
Initiates: Buy
Price Target: $170
Current: $32.05
Upside: +430.42%
Jul 8, 2020
Initiates: Buy
Price Target: $14
Current: $7.09
Upside: +97.46%
Dec 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $0.84
Upside: -
Oct 16, 2018
Maintains: Buy
Price Target: $60 → $40
Current: $1.12
Upside: +3,471.43%
Jul 27, 2018
Maintains: Buy
Price Target: $10 → $12
Current: $16.11
Upside: -25.51%
Jun 22, 2018
Maintains: Buy
Price Target: $52 → $48
Current: $1.83
Upside: +2,522.95%
Jun 1, 2018
Maintains: Buy
Price Target: $8 → $14
Current: $24.81
Upside: -43.57%
May 11, 2018
Maintains: Buy
Price Target: $9 → $12
Current: $25.51
Upside: -52.96%